Apimeds Pharmaceuticals US, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
APUS on NYSE
Industry
Pharmaceutical Preparations
Location
2 East Broad Street, 2 Nd Floor, Hopewell, NJ

There are no Buy or Sell transactions made by insiders since 11/28/2024

Apimeds Pharmaceuticals US, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Inscobee Inc. 10%+ Owner $8.81M May 12, 2025
Erik C. Emerson Chief Executive Officer, Director $1.31M Oct 15, 2025
Christopher Kim Chairman and CMO, Director $486K Oct 15, 2025
Carol A. O'donnell Director Nov 11, 2025
Bennett Weintraub Director Nov 11, 2025
Mark Corrao Chief Financial Officer Mar 4, 2025
Jakap Koo Director Nov 11, 2025
Elona Kogan Director Nov 11, 2025
Hankil Yoon Director Nov 11, 2025

Recent Insider Transactions by Companies or Individuals for Apimeds Pharmaceuticals US, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.